{"id":55318,"date":"2023-03-29T17:03:21","date_gmt":"2023-03-29T15:03:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/"},"modified":"2023-03-29T17:03:21","modified_gmt":"2023-03-29T15:03:21","slug":"tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/","title":{"rendered":"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification"},"content":{"rendered":"<div>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24TIVC&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$TIVC<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/healthcare?src=hash\" target=\"_blank\" rel=\"noopener\">#healthcare<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftivichealth.com&amp;esheet=53370258&amp;newsitemid=20230329005679&amp;lan=en-US&amp;anchor=Tivic+Health%26%23174%3B+Systems%2C+Inc.&amp;index=1&amp;md5=ce7a37fc710dfd6e32f9f986231d745d\" rel=\"nofollow noopener\" shape=\"rect\">Tivic Health\u00ae Systems, Inc.<\/a> (\u201cTivic\u201d) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has completed the supplier qualification and first article inspection of Microart Services, Inc., one of two new partners announced in Q4 of 2022.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230329005679\/en\/1740047\/4\/Tivic_Logo_400x400.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230329005679\/en\/1740047\/21\/Tivic_Logo_400x400.jpg\"><\/a><\/p>\n<p>\nThe supplier qualification and successful first article inspection help confirm that Tivic\u2019s production process is under statistical control and produces safe, high-quality products in compliance with Tivic\u2019s specifications and applicable regulatory requirements.\n<\/p>\n<p>\n\u201cWorking with Microart has allowed us to reduce our printed circuit board manufacturing costs by 70% and increase production capacity by 25X,\u201d said Ryan Sabia, COO of Tivic. \u201cWe expect that this will be an accelerator for scalable growth.\u201d\n<\/p>\n<p>\nTivic\u2019s partnership with two new suppliers, Microart and ALOM, has resulted in:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nUp to a 30% reduction in 3PL costs\n<\/li>\n<li>\nA 40% reduction in final assembly production costs per unit\n<\/li>\n<li>\nUp to 25x increased production capacity\n<\/li>\n<li>\nAn overall COGs reduction forecast for 2023 of 37%\n<\/li>\n<\/ul>\n<p>\n<b>About Tivic<\/b>\n<\/p>\n<p>\nTivic Health Systems, Inc. is a commercial-phase health technology company delivering non-invasive bioelectronic treatments that provide consumers with a choice in the treatment of inflammation and certain other related conditions. For more information visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftivichealth.com&amp;esheet=53370258&amp;newsitemid=20230329005679&amp;lan=en-US&amp;anchor=https%3A%2F%2Ftivichealth.com&amp;index=2&amp;md5=891cfc4b0cfa0a0e94c97e46f5b96282\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/tivichealth.com<\/a> @TivicHealth.\n<\/p>\n<p>\n<b>Forward-Looking Statements<\/b>\n<\/p>\n<p>\n<i>This press release may contain \u201cforward-looking statements\u201d that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cseek,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201cshould,\u201d \u201cwill\u201d \u201cwould,\u201d or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.\u2019s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate.<\/i> <i>Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. Given the existence of risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of certain risks and uncertainties, and other important factors, relevant to the company, any of which could cause Tivic\u2019s actual results to differ from those contained in the forward-looking statements, see Tivic\u2019s filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 31, 2022, under the heading \u201cRisk Factors\u201d; its Registration Statement on S-1, filed with the SEC on October 26, 2022, and amendments thereto, under the heading \u201cRisk Factors\u201d; as well as the company\u2019s subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact:<\/b><br \/>Kayleigh Westerfield<br \/>\n<br \/>949-632-3439<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x4b;&#97;&#x79;&#108;&#x65;&#105;&#x67;&#104;&#x2e;&#87;&#x65;&#115;&#x74;&#101;&#x72;&#102;&#x69;&#101;&#x6c;d&#x40;t&#x69;v&#x69;c&#x68;e&#x61;l&#x74;h&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x4b;&#97;&#x79;&#x6c;&#101;&#x69;&#x67;&#104;&#x2e;&#x57;&#101;&#x73;&#x74;e&#x72;&#x66;i&#x65;&#108;d&#x40;&#116;i&#x76;&#105;c&#x68;&#101;a&#x6c;&#116;h&#x2e;&#99;o&#x6d;<\/a>\n<\/p>\n<p>\n<b>Investor Contact:<\/b><br \/>Hanover International, Inc.<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#105;&#114;&#64;&#116;&#x69;&#x76;&#x69;&#x63;&#x68;&#x65;&#x61;&#x6c;&#x74;h&#46;co&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#114;&#64;&#x74;&#x69;&#118;i&#x63;&#x68;&#101;a&#x6c;&#x74;&#104;&#46;&#x63;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;$TIVC #healthcare&#8212;Tivic Health\u00ae Systems, Inc. (\u201cTivic\u201d) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has completed the supplier qualification and first article inspection of Microart Services, Inc., one of two new partners announced in Q4 of 2022. The supplier qualification and successful first article inspection &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55318","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;$TIVC #healthcare&#8212;Tivic Health\u00ae Systems, Inc. (\u201cTivic\u201d) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has completed the supplier qualification and first article inspection of Microart Services, Inc., one of two new partners announced in Q4 of 2022. The supplier qualification and successful first article inspection ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-29T15:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230329005679\/en\/1740047\/21\/Tivic_Logo_400x400.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification\",\"datePublished\":\"2023-03-29T15:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/\"},\"wordCount\":530,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005679\\\/en\\\/1740047\\\/21\\\/Tivic_Logo_400x400.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/\",\"name\":\"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005679\\\/en\\\/1740047\\\/21\\\/Tivic_Logo_400x400.jpg\",\"datePublished\":\"2023-03-29T15:03:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005679\\\/en\\\/1740047\\\/21\\\/Tivic_Logo_400x400.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005679\\\/en\\\/1740047\\\/21\\\/Tivic_Logo_400x400.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/","og_locale":"en_US","og_type":"article","og_title":"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification - Pharma Trend","og_description":"SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;$TIVC #healthcare&#8212;Tivic Health\u00ae Systems, Inc. (\u201cTivic\u201d) (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has completed the supplier qualification and first article inspection of Microart Services, Inc., one of two new partners announced in Q4 of 2022. The supplier qualification and successful first article inspection ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-29T15:03:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230329005679\/en\/1740047\/21\/Tivic_Logo_400x400.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification","datePublished":"2023-03-29T15:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/"},"wordCount":530,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230329005679\/en\/1740047\/21\/Tivic_Logo_400x400.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/","url":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/","name":"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230329005679\/en\/1740047\/21\/Tivic_Logo_400x400.jpg","datePublished":"2023-03-29T15:03:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230329005679\/en\/1740047\/21\/Tivic_Logo_400x400.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230329005679\/en\/1740047\/21\/Tivic_Logo_400x400.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/tivic-health-systems-inc-cuts-component-manufacturing-costs-by-70-completes-second-key-supplier-qualification\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Tivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55318"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55318\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}